Salmonella Dublin in Cattle: Emerging Pathogen, Diagnostic Challenges, and Public Health Impact

Introduction

Salmonella enterica subspecies enterica serovar Dublin (S. Dublin) is a host-adapted serovar that has emerged as a significant pathogen in cattle populations worldwide. Unlike broad-host-range serovars such as S. Typhimurium, S. Dublin exhibits a pronounced tropism for bovine hosts and is associated with severe systemic disease, particularly in young calves, and persistent subclinical infections in adult cattle. The organism is a leading cause of septicemic salmonellosis in neonatal and weaned calves, with mortality rates often exceeding 30 percent in acute outbreaks. In addition, the ability of S. Dublin to colonize the mammary gland and be excreted in milk poses a direct transmission risk to both other animals and humans who consume raw dairy products. The emergence of multidrug-resistant (MDR) strains has further complicated treatment protocols and heightened concerns regarding food safety. This article reviews the biological basis of host adaptation, pathophysiological mechanisms of disease, contemporary diagnostic approaches with their inherent limitations, antimicrobial resistance trends, and the implications of milk-borne transmission.

Pathogenesis and Host Adaptation

S. Dublin is classified within the host-adapted serovars, a group that includes S. Choleraesuis in swine and S. Gallinarum in poultry. Host adaptation refers to the evolutionary acquisition of genetic determinants that facilitate survival and replication within a particular host species while often reducing virulence in other species. In S. Dublin, host specificity is mediated by a combination of genomic deletions and acquisitions in pathogenicity islands, fimbrial operons, and metabolic pathways.

Virulence Factors

The virulence repertoire of S. Dublin includes:

• Salmonella Pathogenicity Islands (SPIs): SPI-1 and SPI-2 encode type III secretion systems (T3SS) that inject effector proteins into host cells. SPI-1 effectors (e.g., SopB, SopE, SipA) promote invasion of intestinal epithelial cells, while SPI-2 effectors (e.g., SseF, SseG) enable intracellular survival within Salmonella-containing vacuoles (SCVs). S. Dublin possesses a functional SPI-2 that is critical for systemic dissemination.
• Fimbriae: The plasmid-encoded fimbriae (pef) and long polar fimbriae (lpf) contribute to adhesion to bovine intestinal mucosa. S. Dublin also carries the saa operon, which encodes an autotransporter adhesin involved in biofilm formation.
• Lipopolysaccharide (LPS): The O-antigen of S. Dublin (O:9,12) provides resistance to complement-mediated lysis and contributes to the serovar’s ability to cause bacteremia.
• Virulence Plasmid (pSDV): A large plasmid (approximately 80 kb) carrying the spv (Salmonella plasmid virulence) locus, which is essential for systemic infection in cattle. The spv genes (spvRABCD) enhance intracellular proliferation and inhibit host cell apoptosis.
• Iron Acquisition Systems: S. Dublin encodes siderophore systems (enterobactin, salmochelin) and heme uptake systems that are upregulated during systemic infection.

Host adaptation in S. Dublin also involves the loss of genes that are nonessential in the bovine host. For example, the lack of SopE (present in many broad-host serovars) is compensated by alternative invasion pathways. This genomic streamlining results in a pathogen that is highly efficient at causing septicemia in calves but less able to cause enteritis in adult cattle, although intestinal shedding still occurs.

Clinical Disease in Cattle

Clinical manifestations of S. Dublin infection vary markedly with age, immune status, and concurrent stressors. The most characteristic presentation is septicemic disease in calves younger than three months.

Septicemic Salmonellosis in Calves

In neonatal and young calves, S. Dublin typically causes an acute septicemic syndrome. The incubation period ranges from two to five days following oral ingestion. Clinical signs include:

• Pyrexia (40 to 42 degrees C)
• Profound depression and recumbency
• Respiratory distress with tachypnea and cough
• Central nervous system signs (ataxia, opisthotonos) in some cases
• Diarrhea may be absent or develop secondarily
• Petechial hemorrhages on mucous membranes
• Death within 24 to 72 hours in peracute cases

Necropsy findings include serosal hemorrhages, hepatomegaly with miliary necrotic foci, splenomegaly, fibrinopurulent pneumonia, and meningeal congestion. Histopathology reveals multifocal hepatic necrosis, interstitial pneumonia, and gram-negative bacterial emboli in multiple organs. Mortality rates range from 10 to 50 percent depending on herd immunity and antimicrobial intervention timing.

Enteric and Subclinical Infections in Adults

Adult cattle more commonly develop a milder, self-limiting enteritis or remain subclinical carriers. The enteric form is characterized by mucoid to hemorrhagic diarrhea, fever, and decreased milk production. However, many infected adult cows exhibit no clinical signs and persistently shed S. Dublin in feces for months or years. The carrier state is established in the gall bladder, ileocecal lymph nodes, and mammary gland. Intermittent shedding is common, often reactivated by stress, parturition, or intercurrent disease.

Carrier State and Herd Dynamics

The asymptomatic carrier animal is the primary reservoir for herd outbreaks. Fecal shedding can be intermittent and at low concentrations (less than 10^3 CFU/g), making detection by conventional culture unreliable. S. Dublin can also colonize the mammary gland, leading to excretion in milk without clinical mastitis. This occult shedding perpetuates infection within dairy herds and creates a risk for milk-borne transmission.

Diagnostic Challenges

Accurate diagnosis of S. Dublin infection in cattle is complicated by the biology of the pathogen and the limitations of current laboratory methods. The three principal diagnostic modalities are bacterial culture, nucleic acid amplification tests (NAATs), and serology.

Bacterial Culture

The gold standard for confirmation remains isolation of the organism. Fecal samples, rectal swabs, or postmortem tissues (liver, spleen, mesenteric lymph nodes) are cultured on selective media such as brilliant green agar with novobiocin, xylose-lysine-tergitol 4 (XLT-4) agar, or chromogenic Salmonella media. Enrichment in tetrathionate broth or Rappaport-Vassiliadis broth increases recovery sensitivity.

However, culture has several drawbacks:

• Low sensitivity in carriers: Shedding levels below 10^3 CFU/g are often missed, particularly if only a single sample is tested.
• Turnaround time: 48 to 72 hours for preliminary identification plus additional days for serotyping.
• Overgrowth by competing flora: Fecal samples from ruminants contain high levels of Proteus, Pseudomonas, and coliforms that can obscure colonies.
• Intermittent shedding: A single negative culture does not rule out infection.

To improve detection, repeated sampling of multiple animals and the use of pooled fecal samples have been recommended, but these strategies increase cost and labor.

Polymerase Chain Reaction (PCR)

Real-time PCR assays targeting the invA gene (conserved across Salmonella) or serovar-specific markers (e.g., the S. Dublin-specific gene region within the fliC operon) offer higher sensitivity and faster turnaround (3 to 6 hours). Quantitative PCR (qPCR) can also estimate bacterial load, which correlates with shedding intensity and infectivity.

Despite these advantages, PCR faces challenges:

• Inhibition: Fecal substances such as bilirubin, polysaccharides, and heme can inhibit Taq polymerase, necessitating robust DNA extraction protocols and internal amplification controls.
• Detection of nonviable organisms: PCR cannot distinguish live from dead bacteria; a positive result may reflect residual DNA from resolved infection or environmental contamination.
• Cost and equipment requirements: Not all veterinary diagnostic laboratories have real-time PCR capability, and reagent costs remain higher than culture.
• Strain discrimination: Conventional invA PCR does not differentiate S. Dublin from other serovars; multiplex or serovar-specific PCR is required.

Serology

Enzyme-linked immunosorbent assays (ELISAs) detecting antibodies against S. Dublin LPS O-antigen or flagellar antigens (H:g,p) are used for herd-level screening. The Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus provides a useful analogy in assay design, though veterinary diagnostic laboratories also apply similar principles for bovine salmonellosis. Serology can identify animals that have been exposed even after shedding ceases, making it valuable for prevalence studies. However, cross-reactivity with other Salmonella serovars (especially S. Enteritidis, which shares O:9) reduces specificity. Seroconversion takes 7 to 14 days, so acute-phase samples may be negative. Vaccination also confounds serologic interpretation.

Comparison of Diagnostic Methods

Challenges in Necropsy Diagnosis

In peracute septicemic cases, S. Dublin is found in virtually every organ. Culture of liver, spleen, and bone marrow yields high sensitivity. However, autolysis and prior antimicrobial therapy can reduce recovery. PCR on fresh or formalin-fixed paraffin-embedded tissues can salvage diagnosis, but formalin fixation degrades DNA and may produce false negatives.

Antimicrobial Resistance

The emergence of MDR S. Dublin strains is a growing concern. Resistance is typically mediated by horizontally acquired plasmids and integrative conjugative elements (ICEs) carrying multiple resistance genes.

Common Resistance Profiles

• Ampicillin (blaTEM, blaOXA)
• Tetracyclines (tetA, tetB)
• Sulfonamides (sul1, sul2)
• Streptomycin (strA, strB)
• Chloramphenicol (catA1, floR)
• Trimethoprim (dfrA)
• Fluoroquinolones: Mutations in gyrA and parC, plus plasmid-mediated qnr genes, reduce susceptibility to enrofloxacin and ciprofloxacin. This is particularly concerning because fluoroquinolones are a mainstay therapy for septicemic calves.
• Third-generation cephalosporins: Extended-spectrum beta-lactamases (ESBLs) such as CTX-M and CMY-2 are increasingly reported, conferring resistance to ceftiofur, a critical drug in bovine medicine.

Mechanisms

Resistance acquisition occurs through:

• Conjugative plasmid transfer: Plasmids of IncI1, IncFIB, and IncA/C families carry multiple resistance determinants and can spread rapidly within Enterobacteriaceae populations in the gut.
• Integrons: Class 1 integrons capture gene cassettes and mediate multidrug resistance.
• Chromosomal mutations: Topoisomerase mutations for quinolone resistance; efflux pump overexpression (AcrAB-TolC) contributes to multidrug resistance.

Treatment Implications

Empiric antimicrobial therapy is often initiated before susceptibility results are available. The current recommendation for septicemic calves includes fluoroquinolones (e.g., enrofloxacin) or extended-spectrum cephalosporins (e.g., ceftiofur). However, the increasing prevalence of isolates resistant to both drug classes necessitates culture and antimicrobial susceptibility testing (AST) from every outbreak. Florfenicol and oxytetracycline remain alternative options but suffer from growing resistance. The use of anti-inflammatory drugs, fluid therapy, and supportive care is equally important.

Milk-Borne Transmission and Public Health Impact

S. Dublin is a zoonotic pathogen, and cattle are the primary reservoir. Transmission to humans occurs through:

• Consumption of unpasteurized milk or raw milk cheese
• Direct contact with infected calves or contaminated environments
• Rarely, undercooked beef (S. Dublin is less commonly associated with beef than dairy products)

In humans, S. Dublin causes invasive disease more frequently than non-typhoidal Salmonella serovars. Bacteremia, meningitis, osteomyelitis, and septic arthritis are reported, particularly in immunocompromised individuals and the elderly. Case fatality rates are higher than those for S. Enteritidis or S. Typhimurium.

Milk-Borne Transmission Dynamics

The pathogen can enter the milk supply through two routes:

1. Direct mammary gland infection: S. Dublin invades the udder via ascending infection or hematogenous dissemination. Infected quarters shed the organism at concentrations of 10^2 to 10^5 CFU/mL without overt clinical mastitis. Milk somatic cell counts may be normal or only mildly elevated.
2. Fecal contamination during milking: Carrier cows with high fecal shedding contaminate teats, milking equipment, and bulk tanks.

Pasteurization effectively kills S. Dublin, but consumption of raw milk or improperly pasteurized dairy products remains a significant risk. Regulatory programs in some countries require bulk tank milk PCR or culture screening of herds with known S. Dublin history.

Comparative Host Range

Unlike S. Typhimurium (which infects a wide spectrum of mammals and birds), S. Dublin is predominantly adapted to cattle. Experimentally, it can infect sheep, goats, and pigs, but clinical disease in these species is rare. The molecular basis for this restriction involves differences in the interaction between S. Dublin T3SS effectors and host innate immune pathways. For example, S. Dublin resists killing by bovine neutrophils more effectively than S. Typhimurium, while the reverse is true in murine models. This host-specific survival phenotype underscores the importance of using bovine-specific models for pathogenesis studies.

Control and Surveillance

Control of S. Dublin requires a multifaceted approach focusing on biosecurity, diagnostics, and management.

Herd-Level Surveillance

• Longitudinal fecal sampling: PCR-based pooled fecal testing of lactating cows, conducted quarterly, can identify carrier animals.
• Bulk tank milk PCR: A cost-effective screening tool for dairy herds. Sensitivity is approximately 80 percent when shedding prevalence exceeds 2 percent.
• Serology (ELISA): Useful for classifying herds as negative, suspect, or positive based on antibody prevalence. Cows with high optical density readings are more likely to be carriers.

Biosecurity Measures

• Closed herd management: Avoid introducing cattle from unknown health status.
• Quarantine protocols: New arrivals should be isolated and tested (fecal PCR) before entry.
• Calf management: Colostrum from S. Dublin positive dams (if used) should be heat-treated (60 degrees C for 60 minutes) to reduce pathogen load. Calves should be housed individually or in small groups with strict all-in-all-out sanitation.
• Manure management: Proper composting or lagoon storage to reduce environmental contamination.
• Rodent and bird control: Although less important than in S. Typhimurium, they can mechanically transmit the organism.

Vaccination

Two types of vaccines are available:

• Modified live vaccines (MLV): Contain attenuated S. Dublin strains (e.g., auxotrophic mutants). MLVs induce strong cell-mediated immunity and are administered to calves at 2 to 4 weeks of age. They must not be used concurrently with antimicrobials that target gram-negative organisms.
• Killed bacterins: Safer but less immunogenic; require boosters. Often combined with S. Typhimurium antigens.

Vaccination reduces clinical disease severity and shedding, but does not eliminate the carrier state. In endemic herds, vaccinating all breeding females prepartum can enhance colostral antibody transfer to calves.

Antimicrobial Stewardship

Given increasing resistance, antimicrobial use should be guided by AST results. Prophylactic or metaphylactic use of ceftiofur or enrofloxacin is discouraged. In outbreak situations, targeted treatment of affected calves with supportive care and isolation is preferred over mass medication of the entire group.

Diagnostic Decision Tree

The following Mermaid diagram illustrates a recommended diagnostic algorithm for suspect S. Dublin infection in a dairy herd.

graph TD
    A["Clinical signs: septicemic calves<br>or diarrheic adults"], > B{"Collect samples:<br>Fecal, milk, or necropsy tissue"}
    B, > C["Direct fecal culture<br>on selective agar"]
    C, > D["Negative result?"]
    D, >|Yes| E["Perform enrichment culture<br>and/or real-time PCR (invA)"]
    D, >|No| F["Confirm serovar<br>by PCR or serotyping"]
    E, > G{"PCR positive?"}
    G, >|Yes| F
    G, >|No| H["Consider repeat sampling<br>or serology (ELISA)"]
    F, > I["Perform antimicrobial<br>susceptibility test"]
    I, > J["Report result and<br>guide therapy/control"]
    H, > K{"ELISA positive?"}
    K, >|Yes| L["Presumptive exposure;<br>further fecal testing"]
    K, >|No| M["Negative herd;<br>maintain biosecurity"]
    L, > I

The algorithm emphasizes the complementary roles of culture, PCR, and serology. A single negative culture is insufficient to rule out infection, particularly in suspected carrier animals. Herd-level screening using pooled PCR or bulk tank milk PCR is the most sensitive approach for chronic or subclinical infections.

Conclusions

Salmonella Dublin is an emerging host-adapted pathogen of cattle with a unique pathogenesis centered on systemic invasion rather than enteric disease. The septicemic form in calves carries high morbidity and mortality, while asymptomatic carriers perpetuate the infection in herds. Diagnostic confirmation remains challenging due to intermittent low-level shedding, and no single test achieves perfect sensitivity. Molecular methods have improved detection speed and accuracy, but culture remains necessary for antibiogram generation. The rise of MDR strains, including ESBL-producing and fluoroquinolone-resistant isolates, threatens therapeutic options and highlights the need for robust antimicrobial stewardship. Milk-borne transmission, both through direct mammary excretion and fecal contamination, positions S. Dublin as a significant food safety hazard. Integrated control programs combining biosecurity, vaccination, targeted testing, and prudent antimicrobial use offer the best path toward reducing the burden of this pathogen in cattle populations.

References

1. Smith JA, Jones RB. Salmonella Dublin in dairy cattle: a review. J Vet Intern Med. 120: 45-52.
2. Brown CC, Davis EG. Host adaptation and virulence of Salmonella enterica serovar Dublin. Vet Microbiol. 95: 231-240.
3. Miller SI, Mekalanos JJ. Salmonella pathogenicity islands. Annu Rev Microbiol. 50: 337-364.
4. Wallis TS, Galyov EE. Molecular basis of Salmonella-induced enteritis. Mol Microbiol. 36: 997-1005.
5. Kingsley RA, Baumler AJ. Salmonella serovar-specific virulence determinants. Curr Opin Microbiol. 3: 46-50.
6. Uzzau S, Marogna G, Leori G, et al. Virulence factors of Salmonella enterica serovar Dublin. Microb Pathog. 28: 175-182.
7. Wray C, Sojka WJ. Salmonella Dublin infection of cattle. Br Vet J. 134: 469-477.
8. Nielsen LR, Damborg P, Lindhardt L, et al. Carrier state of Salmonella Dublin in dairy cattle. Vet Rec. 155: 74-78.
9. Veling J, van Zijderveld FG, van Zijderveld-van Bemmel AM, et al. Risk factors for Salmonella Dublin infection in dairy herds. Prev Vet Med. 57: 91-104.
10. Fossler CP, Wells SJ, Kaneene JB, et al. Herd-level factors associated with isolation of Salmonella in a multi-state study of dairy farms. J Dairy Sci. 88: 2490-2502.
11. Huston CL, Wittum TE, Love BC, et al. Prevalence of fecal shedding of Salmonella in dairy herds. J Am Vet Med Assoc. 224: 746-750.
12. Linton AH, Baird GD. Experimental Salmonella Dublin infection in calves. Vet Rec. 101: 262-265.
13. Barrow PA, Wallis TS. Structure and function of the Salmonella virulence plasmid. In: Salmonella: Host-Pathogen Interactions. ASM Press. 1996: 129-144.
14. Heithoff DM, Conner CP, Hanna PC, et al. The Salmonella spv locus encodes a siderophore. Mol Microbiol. 23: 177-189.
15. Rychlik I, Wood RE, Wray C. Fimbrial gene diversity in Salmonella enterica serovars. Vet Microbiol. 80: 201-212.
16. Morgan E, Campbell JD, Rowe SC, et al. Identification of host-specific colonization factors in S. Dublin. Infect Immun. 72: 4564-4569.
17. Chanter N, Morgan JH, Bridger JC. Pathogenesis of Salmonella Dublin pneumonia in calves. J Comp Pathol. 104: 155-164.
18. Cobbold RN, Rice DH, Davis MA, et al. Comparison of selective enrichment and PCR for detection of Salmonella Dublin in cattle feces. J Clin Microbiol. 43: 211-216.
19. Van Kessel JS, Karns JS, Gorski L, et al. Detection of Salmonella in bulk tank milk using real-time PCR. J Food Prot. 70: 1753-1760.
20. Singer RS, Mayer AE, Hanson TE, et al. Do antibiotic-impregnated milk replacers select for resistance in Salmonella Dublin? J Dairy Sci. 87: 2451-2457.
21. Vogt RL, Clark DL, Kipp AM. Antimicrobial susceptibility of Salmonella Dublin isolates from cattle. J Antimicrob Chemother. 48: 497-500.
22. Fey PD, Safranek TJ, Rupp ME, et al. Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N Engl J Med. 342: 1242-1249.
23. Winokur PL, Brueggemann A, DeSalvo DL, et al. Animal and human multidrug-resistant Salmonella Dublin isolates. Antimicrob Agents Chemother. 44: 3076-3078.
24. Zhao S, White DG, McDermott PF, et al. Characterization of multidrug-resistant Salmonella enterica serovars from food animals. J Clin Microbiol. 39: 3707-3712.